average weight loss on tirzepatide in 3 months Before and after results: what real transformations look like and what determines success Weight loss just got smarter.

Nonclinical Toxicology 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility A 2-year carcinogenicity study was conducted with tirzepatide in male and female rats at doses of 0.15, 0.50, and 1.5 mg/kg (0.1-, 0.4-, and 1-fold the MRHD of 15 mg once weekly based on AUC) administered by subcutaneous injection twice weekly

53.Linnebjerg H, Kothare PA, Park S, et al

The platform is committed to expanding access as broadly as possible while maintaining full regulatory compliance

Combined, they represent the difference between maintaining on 10 mg and maintaining on 2.5 mg

Excellent customer service

Manufactured by Eli Lilly, Zepbound was approved by the FDA in November 2023 and has rapidly become the most prescribed injectable obesity-management medication in the United States